| Overview of the 2022 WHO classification of thyroid neoplasms ZW Baloch, SL Asa, JA Barletta, RA Ghossein, CC Juhlin, CK Jung, ... Endocrine pathology 33 (1), 27-63, 2022 | 594 | 2022 |
| Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing JW Kunstman, CC Juhlin, G Goh, TC Brown, A Stenman, JM Healy, ... Human molecular genetics 24 (8), 2318-2329, 2015 | 359 | 2015 |
| Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism UI Scholl, G Stölting, C Nelson-Williams, AA Vichot, M Choi, E Loring, ... elife 4, e06315, 2015 | 330 | 2015 |
| Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma J Welander, A Andreasson, CC Juhlin, RW Wiseman, M Bäckdahl, ... The journal of clinical endocrinology & metabolism 99 (7), E1352-E1360, 2014 | 178 | 2014 |
| Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma CC Juhlin, G Goh, JM Healy, AL Fonseca, UI Scholl, A Stenman, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), E493-E502, 2015 | 159 | 2015 |
| Overview of the 2022 WHO classification of adrenal cortical tumors O Mete, LA Erickson, CC Juhlin, RR de Krijger, H Sasano, M Volante, ... Endocrine pathology 33 (1), 155-196, 2022 | 148 | 2022 |
| Overview of the 2022 WHO classification of parathyroid tumors LA Erickson, O Mete, CC Juhlin, A Perren, AJ Gill Endocrine Pathology 33 (1), 64-89, 2022 | 135 | 2022 |
| Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification CC Juhlin, A Villablanca, K Sandelin, F Haglund, J Nordenstrom, ... Endocrine-Related Cancer 14 (2), 501-512, 2007 | 126 | 2007 |
| TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA N Wang, T Liu, A Sofiadis, CC Juhlin, J Zedenius, A Höög, C Larsson, ... Cancer 120 (19), 2965-2979, 2014 | 119 | 2014 |
| Loss of parafibromin expression in a subset of parathyroid adenomas C Juhlin, C Larsson, T Yakoleva, I Leibiger, B Leibiger, A Alimov, ... Endocrine-Related Cancer 13 (2), 509-523, 2006 | 97 | 2006 |
| The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading CC Juhlin, O Mete, ZW Baloch Endocrine-related cancer 30 (2), 2023 | 96 | 2023 |
| The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors T Liu, TC Brown, CC Juhlin, A Andreasson, N Wang, M Bäckdahl, ... Endocrine-related cancer 21 (3), 427-434, 2014 | 92 | 2014 |
| Transcriptional profiling enables molecular classification of adrenocortical tumours C Laurell, D Velázquez-Fernández, K Lindsten, C Juhlin, U Enberg, J Geli, ... European Journal of Endocrinology 161 (1), 141-152, 2009 | 85 | 2009 |
| Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas CC Juhlin, IL Nilsson, K Johansson, F Haglund, A Villablanca, A Höög, ... Endocrine pathology 21, 166-177, 2010 | 82 | 2010 |
| Comprehensive genetic analysis of follicular thyroid carcinoma predicts prognosis independent of histology NG Nicolson, TD Murtha, W Dong, JO Paulsson, J Choi, AL Barbieri, ... The Journal of Clinical Endocrinology & Metabolism 103 (7), 2640-2650, 2018 | 80 | 2018 |
| Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours CC Juhlin, NB Kiss, A Villablanca, F Haglund, J Nordenström, A Höög, ... PloS one 5 (3), e9472, 2010 | 76 | 2010 |
| Metastatic pheochromocytomas and abdominal paragangliomas D Granberg, CC Juhlin, H Falhammar The journal of clinical endocrinology & metabolism 106 (5), e1937-e1952, 2021 | 75 | 2021 |
| The value of histological algorithms to predict the malignancy potential of pheochromocytomas and abdominal paragangliomas—A meta-analysis and systematic review of the literature A Stenman, J Zedenius, CC Juhlin Cancers 11 (2), 225, 2019 | 75 | 2019 |
| Adrenal myelolipomas J Calissendorff, CC Juhlin, A Sundin, I Bancos, H Falhammar The lancet Diabetes & endocrinology 9 (11), 767-775, 2021 | 73 | 2021 |
| Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-β in parathyroid carcinomas CC Juhlin, F Haglund, A Villablanca, L Forsberg, K Sandelin, R Bränström, ... International journal of oncology 34 (2), 481-492, 2009 | 72 | 2009 |
Jan ZedeniusKarolinska Institute在 ki.se 的电子邮件经过验证
